Sotera Health Company (NASDAQ:SHC) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Sotera Health Company (NASDAQ:SHC) have been assigned a consensus rating of “Moderate Buy” from the ten ratings firms that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $20.00.

A number of brokerages have commented on SHC. Wells Fargo & Company cut Sotera Health to an “overweight” rating in a report on Thursday, January 8th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Sotera Health in a research report on Monday, December 29th. BMO Capital Markets started coverage on Sotera Health in a research note on Thursday, November 13th. They issued an “outperform” rating and a $19.00 price objective for the company. JPMorgan Chase & Co. raised their price objective on Sotera Health from $14.00 to $16.00 and gave the company a “neutral” rating in a report on Wednesday, November 5th. Finally, William Blair started coverage on shares of Sotera Health in a report on Thursday, December 18th. They set an “outperform” rating for the company.

Insider Buying and Selling

In other news, CEO Michael B. Jr. Petras sold 434,104 shares of the business’s stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $16.45, for a total transaction of $7,141,010.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Gtcr Investment Xi Llc sold 12,000,000 shares of the stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $15.65, for a total value of $187,800,000.00. Following the completion of the sale, the director directly owned 29,215,301 shares of the company’s stock, valued at approximately $457,219,460.65. This represents a 29.12% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 29,384,104 shares of company stock worth $471,824,511. 47.55% of the stock is owned by insiders.

Hedge Funds Weigh In On Sotera Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Two Seas Capital LP boosted its stake in Sotera Health by 21.1% during the second quarter. Two Seas Capital LP now owns 4,020,867 shares of the company’s stock worth $44,712,000 after buying an additional 699,731 shares during the period. Farther Finance Advisors LLC boosted its position in shares of Sotera Health by 55.9% during the 2nd quarter. Farther Finance Advisors LLC now owns 9,861 shares of the company’s stock worth $110,000 after purchasing an additional 3,534 shares during the period. Public Employees Retirement System of Ohio increased its holdings in Sotera Health by 4.0% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 48,635 shares of the company’s stock valued at $541,000 after purchasing an additional 1,891 shares during the last quarter. Voss Capital LP raised its position in Sotera Health by 50.0% in the second quarter. Voss Capital LP now owns 750,000 shares of the company’s stock valued at $8,340,000 after purchasing an additional 250,000 shares during the period. Finally, Ontario Teachers Pension Plan Board purchased a new stake in Sotera Health in the second quarter valued at approximately $1,179,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Price Performance

Shares of NASDAQ SHC opened at $18.51 on Friday. The firm has a market cap of $5.26 billion, a PE ratio of 97.43 and a beta of 1.82. The firm has a fifty day moving average of $17.56 and a 200 day moving average of $15.87. The company has a debt-to-equity ratio of 4.04, a quick ratio of 2.18 and a current ratio of 2.38. Sotera Health has a one year low of $9.53 and a one year high of $19.85.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.04. The business had revenue of $311.31 million for the quarter, compared to the consensus estimate of $303.63 million. Sotera Health had a net margin of 4.82% and a return on equity of 43.69%. Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. As a group, research analysts predict that Sotera Health will post 0.61 EPS for the current fiscal year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.